BioImagene teams with Rutgers, UPenn for digital pathology
Digital pathology solutions provider BioImagene has collaborated with the University of Pennsylvania School of Medicine in Philadelphia and Rutgers University in New Brunswick, N.J., in the development of diagnostic tool, Companion Algorithms.
The digital pathology tool is intended to diagnose and evaluate prostate cancer through the utilization of BioImagene’s iAnalytics framework and telepathology capabilities in the collaboration on the development and validation of algorithms for diagnostic use, according to the Sunnyvale, Calif.-based company.
Researchers and clinicians from both respective universities will digitize standard prostate biopsy samples by way of BioImagene’s Virtuoso framework, said BioImagene.
The digital pathology tool is intended to diagnose and evaluate prostate cancer through the utilization of BioImagene’s iAnalytics framework and telepathology capabilities in the collaboration on the development and validation of algorithms for diagnostic use, according to the Sunnyvale, Calif.-based company.
Researchers and clinicians from both respective universities will digitize standard prostate biopsy samples by way of BioImagene’s Virtuoso framework, said BioImagene.